29.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$29.39
Aprire:
$29.39
Volume 24 ore:
553.53K
Relative Volume:
1.05
Capitalizzazione di mercato:
$1.36B
Reddito:
$722.68M
Utile/perdita netta:
$134.71M
Rapporto P/E:
10.93
EPS:
2.67
Flusso di cassa netto:
$109.94M
1 W Prestazione:
-3.54%
1M Prestazione:
+36.40%
6M Prestazione:
+5.68%
1 anno Prestazione:
-37.76%
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AMPH
Amphastar Pharmaceuticals Inc
|
29.19 | 1.43B | 722.68M | 134.71M | 109.94M | 2.67 |
![]()
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-12 | Aggiornamento | Needham | Hold → Buy |
2025-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
2024-03-05 | Iniziato | JP Morgan | Overweight |
2023-11-17 | Iniziato | BofA Securities | Neutral |
2023-07-25 | Ripresa | Jefferies | Buy |
2022-10-21 | Ripresa | Jefferies | Buy |
2022-07-29 | Iniziato | CapitalOne | Overweight |
2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
2020-05-01 | Iniziato | Northland Capital | Outperform |
2019-03-13 | Downgrade | Needham | Buy → Hold |
2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
2018-08-10 | Reiterato | Needham | Buy |
2018-03-13 | Reiterato | Needham | Buy |
2017-12-01 | Reiterato | Needham | Buy |
2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
2017-09-27 | Reiterato | Needham | Buy |
2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
2016-08-09 | Reiterato | Needham | Buy |
2016-05-10 | Reiterato | Needham | Buy |
2016-02-19 | Iniziato | Wells Fargo | Outperform |
2015-06-19 | Reiterato | Needham | Buy |
2015-06-03 | Iniziato | Raymond James | Strong Buy |
2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Nuveen LLC Invests $2.77 Million in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Tools to monitor Amphastar Pharmaceuticals Inc. recovery probabilityPortfolio Value Summary & AI Forecasted Entry and Exit Points - Newser
Chart based exit strategy for Amphastar Pharmaceuticals Inc.2025 Major Catalysts & Real-Time Stock Entry Alerts - Newser
Published on: 2025-09-02 14:51:13 - Newser
How to escape a deep drawdown in Amphastar Pharmaceuticals Inc.2025 Momentum Check & Safe Capital Preservation Plans - Newser
Building trade automation scripts for Amphastar Pharmaceuticals Inc.Quarterly Growth Report & Long-Term Capital Growth Ideas - Newser
How to manage a losing position in Amphastar Pharmaceuticals Inc.Weekly Market Summary & Long-Term Growth Stock Strategies - Newser
Risk adjusted return profile for Amphastar Pharmaceuticals Inc. analyzedWeekly Market Report & Daily Profit Maximizing Trade Tips - Newser
Statistical indicators supporting Amphastar Pharmaceuticals Inc.’s strengthBull Run & Technical Pattern Recognition Alerts - Newser
What’s the recovery path for long term holders of Amphastar Pharmaceuticals Inc.2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser
How hedge fund analytics apply to Amphastar Pharmaceuticals Inc. stockJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
How to use a screener to detect Amphastar Pharmaceuticals Inc. breakoutsJobs Report & Smart Swing Trading Alerts - Newser
Amphastar Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Volume & Comprehensive Market Scan Reports - Newser
What recovery options are there for Amphastar Pharmaceuticals Inc.Market Performance Report & Daily Price Action Insights - Newser
Is this a good reentry point in Amphastar Pharmaceuticals Inc.Trade Exit Summary & Low Risk Profit Maximizing Plans - Newser
Will earnings trigger a reversal in Amphastar Pharmaceuticals Inc.Market Trend Summary & Reliable Intraday Trade Plans - Newser
Can Amphastar Pharmaceuticals Inc. hit a new high this monthEarnings Beat & Long-Term Growth Stock Strategies - Newser
Amphastar Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Outlook & Weekly Top Gainers Alerts - Newser
Ranking Amphastar Pharmaceuticals Inc. among high performing stocks via toolsWeekly Profit Summary & Weekly High Conviction Trade Ideas - Newser
Will Amphastar Pharmaceuticals Inc. outperform small cap indexesJuly 2025 Pullbacks & Intraday High Probability Alerts - khodrobank.com
Real time pattern detection on Amphastar Pharmaceuticals Inc. stockPortfolio Value Report & Expert Approved Momentum Ideas - Newser
Is the Options Market Predicting a Spike in Amphastar Pharmaceuticals Stock? - TradingView
Can volume confirm reversal in Amphastar Pharmaceuticals Inc.2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
Published on: 2025-09-02 04:47:08 - Newser
Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection - Yahoo Finance
American Century Companies Inc. Sells 164,024 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Live market analysis of Amphastar Pharmaceuticals Inc.Trade Exit Summary & Trade Opportunity Analysis - Newser
Published on: 2025-09-02 08:34:50 - khodrobank.com
Epoch Investment Partners Inc. Increases Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals Inc. stock chart pattern explainedEarnings Recap Report & Smart Money Movement Tracker - Newser
Can Amphastar Pharmaceuticals Inc. stock double in the next year2025 Macro Impact & Low Volatility Stock Recommendations - khodrobank.com
What analysts say about Amphastar Pharmaceuticals Inc. stockTrade Signal Summary & Free Real-Time Volume Trigger Notifications - khodrobank.com
Is Amphastar Pharmaceuticals Inc. a stock for growth or value investors2025 Top Gainers & Stock Portfolio Risk Control - khodrobank.com
Volume spikes in Amphastar Pharmaceuticals Inc. stock – what they mean2025 Earnings Impact & High Conviction Trade Alerts - Newser
What’s next for Amphastar Pharmaceuticals Inc. stockShare Buyback & Weekly Stock Performance Updates - khodrobank.com
Published on: 2025-09-01 11:27:34 - Newser
How to interpret RSI for Amphastar Pharmaceuticals Inc. stockJuly 2025 Earnings & Expert Verified Movement Alerts - Newser
Amphastar Pharmaceuticals Inc. stock volume spike explainedPortfolio Performance Report & High Return Trade Guides - Newser
Technical Heatmap Flags Amphastar Pharmaceuticals Inc. for Watch getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Amphastar Pharmaceuticals Inc. stock reversal real or fakeWeekly Earnings Recap & Verified Momentum Stock Alerts - Newser
Has Amphastar Pharmaceuticals Inc. found a price floorTrade Risk Assessment & Community Verified Trade Signals - Newser
Charles Schwab Investment Management Inc. Has $9.46 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Custom watchlist performance reports with Amphastar Pharmaceuticals Inc.2025 Volume Leaders & AI Powered Trade Plan Recommendations - Newser
What makes Amphastar Pharmaceuticals Inc. stock price move sharplyMarket Risk Summary & Technical Pattern Based Signals - Newser
Using Bollinger Bands to evaluate Amphastar Pharmaceuticals Inc.Watch List & Trade Opportunity Analysis - Newser
Exit strategy if you’re trapped in Amphastar Pharmaceuticals Inc.Earnings Risk Report & Technical Confirmation Alerts - Newser
Published on: 2025-08-31 16:00:23 - Newser
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):